Medplus Health IPO is a book build issue of ₹1,398.29 crores. The issue is a combination of fresh issue of 0.75 crore shares aggregating to ₹600.31 crores and offer for sale of 1.00 crore shares aggregating to ₹797.98 crores.
Medplus Health IPO bidding started from Dec 13, 2021 and ended on Dec 15, 2021. The allotment for Medplus Health IPO was finalized on Dec 20, 2021. The shares got listed on BSE, NSE on Dec 23, 2021.
Medplus Health IPO price band is set at ₹796.00 per share . The lot size for an application is 18. The minimum amount of investment required by an retail is ₹14,040 (18 shares). The lot size investment for sNII is 14 lots (252 shares), amounting to ₹2,00,592, and for bNII, it is 70 lots (1,260 shares), amounting to ₹10,02,960.
The issue includes a reservation of up to 69,637 shares for employees offered at a discount of ₹78.00 to the issue price.
Axis Capital Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue.
Refer to Medplus Health IPO RHP for detailed Information.
IPO Date | December 13, 2021 to December 15, 2021 |
Listing Date | December 23, 2021 |
Face Value | ₹2 per share |
Issue Price Band | ₹780 to ₹796 per share |
Issue Price Final | ₹796 per share |
Lot Size | 18 Shares |
Sale Type | Fresh Capital-cum-Offer for Sale |
Total Issue Size | 1,75,73,342 shares (aggregating up to ₹1,398.29 Cr) |
Fresh Issue | 75,44,511 shares (aggregating up to ₹600.31 Cr) |
Offer for Sale | 1,00,28,831 shares of ₹2 (aggregating up to ₹797.98 Cr) |
Employee Discount | ₹78.00 |
Issue Type | Bookbuilding IPO |
Listing At | BSE, NSE |
Share Holding Pre Issue | 11,17,61,165 shares |
Share Holding Post Issue | 11,93,05,676 shares |
Medplus Health IPO offers total 1,75,73,342 shares. Out of which 87,51,852 (49.80%) allocated to QIB, 35,00,741 (19.92%) allocated to QIB, 26,25,556 (14.94%) allocated to NII, 61,26,297 (34.86%) allocated to RII and 52,51,111 (29.88%) allocated to Anchor investors.
Investor Category | Shares Offered | Maximum Allottees |
---|---|---|
QIB Shares Offered | 87,51,852 (49.80%) | NA |
− Anchor Investor Shares Offered | 52,51,111 (29.88%) | NA |
− QIB (Ex. Anchor) Shares Offered | 35,00,741 (19.92%) | NA |
NII (HNI) Shares Offered | 26,25,556 (14.94%) | NA |
Retail Shares Offered | 61,26,297 (34.86%) | 3,40,349 |
Employee Shares Offered | 69,637 (0.40%) | NA |
Total Shares Offered | 1,75,73,342 (100.00%) |
Application Category | Maximum Bidding Limits | Bidding at Cut-off Price Allowed |
---|---|---|
Only RII | Up to Rs 2 Lakhs | Yes |
Only sNII | Rs 2 Lakhs to Rs 10 Lakhs | No |
Only bNII | Rs 10 Lakhs to NII Reservation Portion | No |
Only employee | Yes | |
Employee + RII/NII |
|
Yes for Employee and RII/NII |
Medplus Health IPO raises ₹417.99 crore from anchor investors. Medplus Health IPO Anchor bid date is December 12, 2021. Medplus Health IPO Anchor Investors list
Bid Date | December 12, 2021 |
Shares Offered | 52,51,111 |
Anchor Portion Size (In Cr.) | 417.99 |
Anchor lock-in period end date for 50% shares (30 Days) | January 19, 2022 |
Anchor lock-in period end date for remaining shares (90 Days) | March 20, 2022 |
Medplus Health IPO opens on December 13, 2021, and closes on December 15, 2021.
IPO Open Date | Mon, Dec 13, 2021 |
IPO Close Date | Wed, Dec 15, 2021 |
Tentative Allotment | Mon, Dec 20, 2021 |
Initiation of Refunds | Tue, Dec 21, 2021 |
Credit of Shares to Demat | Wed, Dec 22, 2021 |
Tentative Listing Date | Thu, Dec 23, 2021 |
Cut-off time for UPI mandate confirmation | 5 PM on Wed, Dec 15, 2021 |
Investors can bid for a minimum of 18 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
Application | Lots | Shares | Amount |
---|---|---|---|
Retail (Min) | 1 | 18 | ₹14,328 |
Retail (Max) | 13 | 234 | ₹1,86,264 |
S-HNI (Min) | 14 | 252 | ₹2,00,592 |
S-HNI (Max) | 69 | 1,242 | ₹9,88,632 |
B-HNI (Min) | 70 | 1,260 | ₹10,02,960 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Incorporated in 2006, Medplus Health Services is India's second-largest pharmacy retailer in terms of the number of stores and revenue. The company offers pharmaceutical and wellness products i.e. medicines, vitamins, medical devices, test kits, and fast-moving consumer goods i.e. home and personal care products, baby care products, sanitizers, soaps, and detergents, etc. It is also the first pharmacy retailer in India to offer an omnichannel platform wherein customers can purchase products through stores, place orders over the telephone, online orders, and a Click and Pick facility.
As of June 31, 2021, the company has a strong pharmacy retail network of 2,165 stores across Tamil Nadu, Andhra Pradesh, Telangana, Karnataka, Odisha, West Bengal, and Maharashtra. In fiscal 2021, its share of the organized pharmacy retail based on revenue from operations in Chennai, Bangalore, Hyderabad, and Kolkata reported at 30%, 29%, 30%, and 22% respectively. It follows a cluster-based approach for store network expansion wherein it first opens high store density in a populated residential area within a target market. The company's warehouses are located in Bengaluru, Chennai, Hyderabad, Vijaywada, Kolkata, Pune, Bhubaneshwar, Mumbai, and Nagpur.
Competitive strengths
Particulars | For the year/period ended (₹ in Millions) | ||||
---|---|---|---|---|---|
30-Sep-21 | 31-Mar-21 | 31-Mar-20 | 31-Mar-19 | ||
Total Assets | 17,464.94 | 15,656.58 | 13,486.96 | 9,587.11 | |
Total Revenue | 18,908.99 | 30,908.14 | 28,878.87 | 22,849.40 | |
Profit After Tax | 663.67 | 631.11 | 17.94 | 119.22 |
[Dilip Davda] After a dismal performance for FY20, the company posted super earnings and based on these earnings, it has priced its IPO very aggressively. While the sustainability of such margins going forward raises concern, pricing of the IPO too appears greedy. Cash surplus investors may consider an investment with a long-term perspective, others may ignore. Read detail review...
Listing Date | December 23, 2021 |
BSE Script Code | 543427 |
NSE Symbol | MEDPLUS |
ISIN | INE804L01022 |
Final Issue Price | ₹796 per share |
BSE Listing Group | B |
Medplus Health Services Ltd.
707, 7th Floor, 5-9-13,
Taramandal Commercial Complex, Saifabad
Hyderabad 500 004
Hyderabad, Telangana
Phone: +91 040 6724 6724
Email: cs@medplusindia.com
Website: http://www.medplusindia.com/
Kfin Technologies Ltd.
Phone: 04067162222, 04079611000
Email: medplus.ipo@kfintech.com
Website: https://ipostatus.kfintech.com/
Medplus Health IPO is a main-board IPO of 1,75,73,342 equity shares of the face value of ₹2 aggregating up to ₹1,398.29 Crores. The issue is priced at ₹796 per share. The minimum order quantity is 18.
The IPO opens on December 13, 2021, and closes on December 15, 2021.
Kfin Technologies Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Medplus Health IPO using UPI as a payment gateway. Zerodha customers can apply in Medplus Health IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Medplus Health IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Medplus Health IPO opens on December 13, 2021 and closes on December 15, 2021.
Medplus Health IPO lot size is 18, and the minimum amount required for application is ₹14,328.
You can apply in Medplus Health IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Medplus Health IPO will be done on Monday, December 20, 2021, and the allotted shares will be credited to your demat account by Wednesday, December 22, 2021. Check the Medplus Health IPO allotment status.
The Medplus Health IPO listing date is on Thursday, December 23, 2021.
Useful Articles